0.55Open0.55Pre Close0 Volume200 Open Interest1.00Strike Price0.00Turnover385.17%IV8.72%PremiumOct 18, 2024Expiry Date0.51Intrinsic Value100Multiplier19DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type-0.6411Delta0.8646Gamma0.86Leverage Ratio-0.0042Theta-0.0004Rho-0.55Eff Leverage0.0004Vega
Renovaro Stock Discussion
Globe Newswire 17-Sep-2024 9:00 AM
NEWS
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
RenovaroCube acquires 100% ownership of Cyclomics, solidifying their collaboration in cancer diagnostics.
The partnership with Oxford Nanopore and Nvidia enhances RenovaroCube's capabilities in early cancer detection and treatment monitoring.
RenovaroCube's open architecture AI platform combined with Cyclomics' 4th generation molecular technology enables accurate ...
The two companies have agreed to merge, with artificial intelligence medical technology firm GEDi becoming a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.
No comment yet